Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Schwarzer C.

Pharmacol Ther. 2009 Sep;123(3):353-70. doi: 10.1016/j.pharmthera.2009.05.006. Epub 2009 May 28. Review.

2.

Opioids in chronic pain.

Przewłocki R, Przewłocka B.

Eur J Pharmacol. 2001 Oct 19;429(1-3):79-91. Review.

PMID:
11698029
3.

L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry.

Hanrieder J, Ljungdahl A, Fälth M, Mammo SE, Bergquist J, Andersson M.

Mol Cell Proteomics. 2011 Oct;10(10):M111.009308. doi: 10.1074/mcp.M111.009308. Epub 2011 Jul 6.

4.
5.

Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides.

Shukla VK, Lemaire S.

J Psychiatry Neurosci. 1992 Sep;17(3):106-19. Review.

6.

Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor.

Merg F, Filliol D, Usynin I, Bazov I, Bark N, Hurd YL, Yakovleva T, Kieffer BL, Bakalkin G.

J Neurochem. 2006 Apr;97(1):292-301. Epub 2006 Mar 3.

7.
8.

Cytotoxic effects of dynorphins through nonopioid intracellular mechanisms.

Tan-No K, Cebers G, Yakovleva T, Hoon Goh B, Gileva I, Reznikov K, Aguilar-Santelises M, Hauser KF, Terenius L, Bakalkin G.

Exp Cell Res. 2001 Sep 10;269(1):54-63.

PMID:
11525639
9.

Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.

Zhou L, Stahl EL, Lovell KM, Frankowski KJ, Prisinzano TE, Aubé J, Bohn LM.

Neuropharmacology. 2015 Dec;99:131-41. doi: 10.1016/j.neuropharm.2015.07.001. Epub 2015 Jul 6.

10.

Pronociceptive role of dynorphins in uninjured animals: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation.

Tan-No K, Takahashi H, Nakagawasai O, Niijima F, Sato T, Satoh S, Sakurada S, Marinova Z, Yakovleva T, Bakalkin G, Terenius L, Tadano T.

Pain. 2005 Feb;113(3):301-9.

PMID:
15661437
11.

Dynorphin--still an extraordinarily potent opioid peptide.

Chavkin C.

Mol Pharmacol. 2013 Apr;83(4):729-36. doi: 10.1124/mol.112.083337. Epub 2012 Nov 14. Review.

13.

Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2.

Mizoguchi H, Watanabe H, Hayashi T, Sakurada W, Sawai T, Fujimura T, Sakurada T, Sakurada S.

J Pharmacol Exp Ther. 2006 Apr;317(1):362-8. Epub 2006 Jan 4.

14.

Nociceptive behavior induced by the endogenous opioid peptides dynorphins in uninjured mice: evidence with intrathecal N-ethylmaleimide inhibiting dynorphin degradation.

Tan-No K, Takahashi H, Nakagawasai O, Niijima F, Sakurada S, Bakalkin G, Terenius L, Tadano T.

Int Rev Neurobiol. 2009;85:191-205. doi: 10.1016/S0074-7742(09)85015-0. Review.

PMID:
19607971
15.

Content of dynorphins and kappa-opioid receptors in distinct brain regions of C57BL/6 and DBA/2 mice.

Jamensky NT, Gianoulakis C.

Alcohol Clin Exp Res. 1997 Nov;21(8):1455-64.

PMID:
9394118
16.

Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone.

Wittmann W, Schunk E, Rosskothen I, Gaburro S, Singewald N, Herzog H, Schwarzer C.

Neuropsychopharmacology. 2009 Feb;34(3):775-85. doi: 10.1038/npp.2008.142. Epub 2008 Sep 17.

17.

Pathobiology of dynorphins in trauma and disease.

Hauser KF, Aldrich JV, Anderson KJ, Bakalkin G, Christie MJ, Hall ED, Knapp PE, Scheff SW, Singh IN, Vissel B, Woods AS, Yakovleva T, Shippenberg TS.

Front Biosci. 2005 Jan 1;10:216-35. Print 2005 Jan 1. Review.

18.

Noribogaine is a G-protein biased κ-opioid receptor agonist.

Maillet EL, Milon N, Heghinian MD, Fishback J, Schürer SC, Garamszegi N, Mash DC.

Neuropharmacology. 2015 Dec;99:675-88. doi: 10.1016/j.neuropharm.2015.08.032. Epub 2015 Aug 21.

19.

Autoradiographic visualization of kappa opioid receptors with labelled dynorphins in guinea pig brain.

Slater P, Cross AJ, Hewitt L, Savage WJ.

J Recept Res. 1989;9(2):171-80.

PMID:
2568485
20.

Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.

Xu M, Petraschka M, McLaughlin JP, Westenbroek RE, Caron MG, Lefkowitz RJ, Czyzyk TA, Pintar JE, Terman GW, Chavkin C.

J Neurosci. 2004 May 12;24(19):4576-84.

Supplemental Content

Support Center